Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.
OBJECTIVE
In a previous study, we showed that activation of a transfected human erythropoietin receptor (EPOR) in the murine myeloid cell line 32D resulted in the development of morphologic features of granulocytic differentiation and expression of the neutrophil primary granule protein myeloperoxidase. We now studied if EPOR signaling could also mediate secondary granule protein gene expression and investigated the signal transduction requirements for induction of secondary granule gene expression in 32D cells.


METHODS
Wild-type and variant 32D cells expressing normal or chimeric EPORs or receptors for granulocyte colony-stimulating factor (G-CSFRs) were stimulated with EPO or G-CSF and the expression of granulocyte-specific genes was analyzed by Northern blot analysis. To determine the signaling mechanisms required for secondary granule protein gene induction, the activation of STAT pathways following growth factor stimulation was studied by Western blot analysis.


RESULTS
We found that EPO treatment of 32D cells engineered to express EPOR did not result in induction of the secondary granule protein genes encoding lactoferrin and 24p3 lipocalin, the mouse homolog of human N-Gal, or the myeloid transcription factor C/EBPepsilon. Replacement of the intracellular domain of EPOR with the intracellular domain of G-CSFR in a chimeric receptor was associated with EPO-mediated induction of lactoferrin, 24p3 lipocalin, and C/EBPepsilon genes. We found that STAT3 phosphorylation was mediated by the intracellular domain of G-CSFR, but not EPOR. Replacement of one or two of the STAT5 binding sites in the intracytoplasmic domain of the EPOR with STAT3 binding sites resulted in EPO-mediated STAT3 activation and a marked increase in the expression of the 24p3 lipocalin gene. Knockdown of STAT3 protein levels with siRNA caused significant decrease in 24p3 lipocalin gene induction.


CONCLUSIONS
These results indicate that EPOR signaling cannot substitute for G-CSFR signaling to stimulate secondary granule protein gene expression in 32D cells. In addition, STAT3 is a critical mediator of 24p3 lipocalin gene expression in these cells.
Wang
Lei
L
Department of Medicine, Yale University School of Medicine, New Haven, CT 06520-8021, USA.
Arcasoy
Murat O
MO
Watowich
Stephanie S
SS
Forget
Bernard G
BG
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002460:Cell Line; D003594:Cytoplasmic Granules / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D004921:Erythropoietin / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D006098:Granulocytes / Q000502:physiology*; D006801:Humans; D051379:Mice; D014176:Protein Biosynthesis / Q000187:drug effects* / Q000502:physiology; D017467:Receptors, Erythropoietin / Q000235:genetics / Q000378:metabolism; D016188:Receptors, Granulocyte Colony-Stimulating Factor / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins; D050796:STAT3 Transcription Factor; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D015534:Trans-Activators / Q000378:metabolism*; D015533:Transcriptional Activation
D004268:DNA-Binding Proteins; D017467:Receptors, Erythropoietin; D016188:Receptors, Granulocyte Colony-Stimulating Factor; D011994:Recombinant Proteins; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C494087:Stat3 protein, mouse; D015534:Trans-Activators; D004921:Erythropoietin
Jpn J Cancer Res. 1989 Nov;80(11):1077-82
2481663
J Endocrinol. 1999 Jul;162(1):11-9
10396016
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2140-4
1312714
Chin Med J (Engl). 1992 Sep;105(9):707-12
1283843
Blood. 1993 May 1;81(9):2223-36
8481505
Cell. 1993 Jul 30;74(2):227-36
8343951
Blood. 1994 Feb 1;83(3):799-807
8298140
Intern Med. 1993 Aug;32(8):648-50
7508772
Blood. 1994 Sep 15;84(6):1737-46
7521686
Blood. 1994 Sep 15;84(6):1760-4
7521688
Blood. 1995 Feb 1;85(3):812-7
7833481
Curr Opin Cell Biol. 1994 Dec;6(6):804-8
7880526
Immunity. 1999 Aug;11(2):153-61
10485650
Science. 1995 Aug 25;269(5227):1108-12
7652557
Nature. 1995 Oct 19;377(6550):591-4
7566171
EMBO J. 1995 Nov 15;14(22):5557-68
8521813
EMBO J. 1996 May 15;15(10):2434-41
8665851
Gene. 1996 May 8;170(2):173-80
8666241
Blood. 1996 Aug 1;88(3):761-77
8704229
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8324-8
8710869
J Biol Chem. 1996 Oct 4;271(40):24753-60
8798745
Blood. 1996 Oct 1;88(7):2442-9
8839834
Immunity. 1996 Nov;5(5):491-501
8934575
Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):569-74
9012825
Blood. 1997 Jun 15;89(12):4628-35
9192789
J Leukoc Biol. 1999 Nov;66(5):727-32
10577501
Oncogene. 2000 May 15;19(21):2612-8
10851060
J Biol Chem. 2000 Aug 25;275(34):26566-75
10858439
Biochim Biophys Acta. 2000 Oct 18;1482(1-2):272-83
11058768
Curr Opin Hematol. 2001 Jan;8(1):23-7
11138622
Immunity. 2001 Feb;14(2):193-204
11239451
Curr Opin Cell Biol. 2001 Apr;13(2):211-7
11248555
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8000-5
11438745
Blood. 2001 Aug 15;98(4):897-905
11493431
Oncogene. 2001 Oct 29;20(49):7178-85
11704846
Eur J Haematol. 2001 Aug;67(2):77-87
11722594
Oncogene. 2002 May 13;21(21):3295-313
12032771
Immunity. 2002 Jul;17(1):63-72
12150892
Mol Cell. 2002 Nov;10(5):1033-43
12453412
Blood. 2003 Apr 15;101(8):2990-5
12672695
J Biol Regul Homeost Agents. 2003 Jan-Mar;17(1):46-65
12757021
Exp Hematol. 2003 Dec;31(12):1310-6
14662339
Blood. 2004 Mar 1;103(5):1693-701
14604978
Cell. 1989 Apr 21;57(2):277-85
2539263
Blood. 1997 Jul 15;90(2):489-519
9226149
Science. 1997 Sep 12;277(5332):1630-5
9287210
Blood. 1997 Oct 1;90(7):2784-95
9326246
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13187-92
9371821
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6573-5
9618452
Blood. 1998 Jul 15;92(2):345-7; discussion 352
9657727
Blood. 1998 Jul 15;92(2):348-51; discussion 352
9657728
Blood. 1998 Jul 15;92(2):353-61
9657731
Blood. 1998 Aug 15;92(4):1219-24
9694710
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):698-702
9892696
J Biol Chem. 1999 May 21;274(21):14956-62
10329697
Blood. 1999 Jun 15;93(12):4154-66
10361113
Blood. 1999 Jul 1;94(1):39-45
10381496
Blood. 1991 Feb 1;77(3):419-34
1991159